Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF

NCT07687212 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure, Preserved Ejection Fraction

Interventions

DRUG: Henggliflozin Combined with Probiotics
DRUG: Henggliflozin
DRUG: double placebo

Sponsor

The First Affiliated Hospital of Air Force Medicial University